🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Colorado
Clinical trial register · United States · industry-sponsored

Clinical Trials in Colorado, 2026

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a US site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full US registry across all sponsors runs to over 22,000 recruiting studies alone.

Download CSV
Source: ClinicalTrials.gov. Complete coverage of the industry-sponsored slice — all 9115 matching records are in this view (non-industry sponsors are out of scope by design, not truncated). Synced 24 Sep 2026, 03:16 UTC
9115
Studies in scope
industry-sponsored, all four open statuses
4955
Recruiting now
open to new participants
2206
Lead sponsors
across recruiting studies
Top states
California 5299 Florida 4396 Illinois 2477 Georgia 2346 Arizona 2230
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca88 Janssen Research & Development, LLC69 Eli Lilly and Company65 Merck Sharp & Dohme LLC64 Novartis Pharmaceuticals56
State
California5299 Florida4396 Illinois2477 Georgia2346 Arizona2230
All 51 states
Target enrolment
to

Trials with a site in Colorado

2067 of 9115 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Active, closed
A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer
NCT02716116Carcinoma, Non-Small-Cell Lung
Takeda
Phase 1/2
334
Alabama, Arizona, California, Colorado, Florida, Georgia, Illinois, Indiana
2016-06-16
Active, closed
A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's Disease
NCT02726386Parkinson's Disease
NeuroDerm Ltd.
Phase 2
214
Arizona, Arkansas, California, Colorado, Florida, Illinois, Iowa, Maryland
2016-05-04
Active, closed
Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options
NCT02650401Solid Tumors, CNS Tumors
Hoffmann-La Roche
Phase 1/2
69
California, Colorado, Georgia, Illinois, Maryland, Massachusetts, Missouri, New York
2016-05-03
Active, closed
Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)
NCT02768363Prostate Cancer
Candel Therapeutics, Inc.
Phase 2
187
Colorado, Illinois, Louisiana, Maryland, Missouri, Nevada, New Jersey, New York
2016-05
Active, closed
Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients
NCT02701283Aortic Valve Stenosis
Medtronic Cardiovascular
Not applicable
2,223
Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana
2016-03
Active, closed
PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis
NCT02675114Aortic Stenosis
Edwards Lifesciences
Not applicable
1,000
Alabama, Arizona, California, Colorado, Connecticut, Florida, Georgia, Hawaii
2016-03
Active, closed
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
NCT02671435Advanced Solid Tumors
MedImmune LLC
Phase 1/2
383
Alabama, Arizona, California, Colorado, Florida, Illinois, Maryland, Massachusetts
2016-02-22
Active, closed
Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule)
NCT02736656Attention-Deficit/Hyperactivity Disorder
Supernus Pharmaceuticals, Inc.
Phase 3
1,400
Arkansas, California, Colorado, Florida, Oklahoma, Tennessee, Texas, Utah
2016-02-02
By invitation
A Clinical Registry of Orthobiologics Procedures
NCT03011398Orthopedic Disorder
Regenexx, LLC
Observational
50,000
Arizona, California, Colorado, Florida, Illinois, Iowa, Kentucky, Louisiana
2016-02
Active, closed
Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study
NCT02584933ALK Positive Malignancies
Novartis Pharmaceuticals
Phase 4
233
Arkansas, California, Colorado, Maryland, New Jersey
2015-12-11
Active, closed
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate
NCT02629159Rheumatoid Arthritis
AbbVie
Phase 3
1,629
Alabama, Arizona, California, Colorado, Florida, Georgia, Idaho, Illinois
2015-12-01
Active, closed
A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC
NCT02489318Prostate Cancer
Aragon Pharmaceuticals, Inc.
Phase 3
1,052
Alabama, Arizona, California, Colorado, Connecticut, Florida, Illinois, Indiana
2015-11-27
Active, closed
An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS
NCT02531516Prostatic Neoplasms
Aragon Pharmaceuticals, Inc.
Phase 3
1,503
Alabama, Arizona, California, Colorado, Connecticut, Florida, Idaho, Illinois
2015-11-19
Active, closed
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
NCT02568267Breast Cancer, Cholangiocarcinoma, Colorectal Cancer, Head and Neck Neoplasms
Hoffmann-La Roche
Phase 2
534
Arizona, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Illinois
2015-11-19
Active, closed
Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer
NCT02516241Urothelial Cancer
AstraZeneca
Phase 3
1,126
California, Colorado, Connecticut, Florida, Georgia, Kentucky, Massachusetts, Michigan
2015-11-02
Active, closed
AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy.
NCT02511106Stage IB-IIIA Non-small Cell Lung Carcinoma
AstraZeneca
Phase 3
682
California, Colorado, Connecticut, Florida, Georgia, Hawaii, Illinois, Maryland
2015-10-21
Active, closed
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)
NCT02612454Atopic Dermatitis
Regeneron Pharmaceuticals
Phase 3
880
Alabama, Arizona, California, Colorado, District of Columbia, Florida, Georgia, Illinois
2015-10-15
Recruiting
Selinexor and Backbone Treatments of Multiple Myeloma Patients
NCT02343042Multiple Myeloma
Karyopharm Therapeutics Inc
Phase 1/2
300
Arizona, California, Colorado, Massachusetts, Nebraska, New Jersey, New York, North Carolina
2015-10
Active, closed
An Open Label Study of CM-AT for the Treatment of Children With Autism
NCT02649959Autism
Curemark
Phase 3
405
Arizona, Arkansas, California, Colorado, Connecticut, Florida, Indiana, Louisiana
2015-10
Active, closed
Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease
NCT02402660Stargardt Disease, Stargardt Macular Degeneration, Stargardt Macular Dystrophy, Autosomal Recessive Stargardt Disease 1 (ABCA4-related)
Alkeus Pharmaceuticals, Inc.
Phase 2
160
Arizona, California, Colorado, Florida, Indiana, Maryland, Michigan, New York
2015-08
Recruiting
Total Shoulder Arthroplasty Multi-Center Registry
NCT03511586Shoulder Arthroplasty
Arthrex, Inc.
Observational
2,500
Arizona, Colorado, Connecticut, Florida, Illinois, Indiana, Michigan, Missouri
2015-07-28
Active, closed
Acalabrutinib, Obinutuzumab and Chlorambucil in Treatment naïve CLL
NCT02475681Chronic Lymphocytic Leukemia
Acerta Pharma BV
Phase 3
535
Arizona, California, Colorado, District of Columbia, Florida, Illinois, Indiana, Kansas
2015-06-26
Recruiting
Clinical Outcomes Study of the Nexel Total Elbow
NCT02469662Elbow Joint Destruction, Post-traumatic Lesions, Ankylosed Joints, Advanced Rheumatoid Arthritis
Zimmer Biomet
Not applicable
134
Colorado, North Carolina, Pennsylvania, Tennessee
2015-06
Active, closed
A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Previously Untreated Participants With EGFR Mutation-Positive Metastatic NSCLC (RELAY)
NCT02411448Metastatic Non-Small Cell Lung Cancer
Eli Lilly and Company
Phase 3
545
California, Colorado, Hawaii, Kansas, New York, North Carolina, Pennsylvania
2015-05-06
Active, closed
An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer
NCT02365597Urothelial Cancer
Janssen Research & Development, LLC
Phase 2
239
Arizona, California, Colorado, District of Columbia, Illinois, Iowa, Kentucky, Minnesota
2015-04-22
Recruiting
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
NCT02332668Melanoma, Lymphoma, Solid Tumor, Classical Hodgkin Lymphoma
Merck Sharp & Dohme LLC
Phase 1/2
370
Colorado, Illinois, Massachusetts, New York, North Dakota, South Dakota, Texas
2015-03-19
Active, closed
Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients
NCT02362503HIV Infections
ViiV Healthcare
Phase 3
371
California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Illinois, Indiana
2015-02-23
Active, closed
Infusion of Apomorphine: Long-term Safety Study
NCT02339064Idiopathic Parkinson's Disease
MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals
Phase 3
99
Arizona, California, Colorado, Florida, Georgia, Illinois, Kansas, Michigan
2015-02
By invitation
Registry of Patients With Hypophosphatasia
NCT02306720Hypophosphatasia (HPP)
Alexion Pharmaceuticals, Inc.
Observational
1,571
Colorado, Connecticut, Florida, Georgia, Maryland, Massachusetts, Minnesota, Missouri
2015-01-20
Active, closed
Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
NCT02319837Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate
Pfizer
Phase 3
1,068
Alabama, Alaska, Arizona, California, Colorado, Connecticut, Florida, Georgia
2014-12-17
Active, closed
An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)
NCT02257736Prostatic Neoplasms
Aragon Pharmaceuticals, Inc.
Phase 3
982
Arizona, California, Colorado, Florida, Georgia, Illinois, Louisiana, Maine
2014-11-26
Active, closed
A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001)
NCT02293980ccRCC, RCC, Kidney Cancer, Clear Cell Renal Cell Carcinoma
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 1
110
California, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana, Maryland
2014-11-25
Active, closed
Electrical Nerve Block for Amputation Pain
NCT02221934Post-Amputation Pain, Phantom Limb Pain, Residual Limb Pain, Stump Pain
Neuros Medical, Inc.
Not applicable
607
Arizona, Arkansas, Colorado, Florida, Georgia, Illinois, Kentucky, Louisiana
2014-10-09
Active, closed
A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer
NCT02152631Non Small Cell Lung Cancer
Eli Lilly and Company
Phase 3
453
Arkansas, California, Colorado, Delaware, Florida, Georgia, Illinois, Indiana
2014-10-03
Active, closed
An Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenström Macroglobulinemia
NCT02180724Waldenström Macroglobulinemia (WM)
Acerta Pharma BV
Phase 2
107
California, Colorado, District of Columbia, Minnesota, New York, Tennessee, Texas, Washington
2014-09-11
Active, closed
A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD)
NCT02130362Crohn's Disease
AbbVie
Observational
1,446
Alabama, Arizona, California, Colorado, Connecticut, Florida, Georgia, Louisiana
2014-08-28
Active, closed
Persona Total Knee Arthroplasty Outcomes Study
NCT02255383Knee Pain Chronic, Osteoarthritis, Rheumatoid Arthritis, Traumatic Arthritis
Zimmer Biomet
Not applicable
737
Colorado, Illinois, Indiana, North Carolina, Ohio, Pennsylvania, Tennessee, Texas
2014-07
Active, closed
PERIGON Pivotal Trial
NCT02088554Aortic Stenosis
Medtronic Cardiac Surgery
Not applicable
1,312
California, Colorado, Connecticut, Florida, Georgia, Maryland, Massachusetts, Michigan
2014-05-12
Active, closed
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
NCT02032823Breast Cancer
AstraZeneca
Phase 3
1,837
Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware
2014-04-22
Recruiting
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
NCT02071134Parkinson's Disease
Boston Scientific Corporation
Observational
1,500
California, Colorado, Florida, Idaho, Illinois, Indiana, Massachusetts, Missouri
2014-03-04
Active, closed
Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV
NCT02016924Acquired Immune Deficiency Syndrome (AIDS), HIV Infections
Gilead Sciences
Phase 2/3
133
California, Colorado, District of Columbia, Florida, Tennessee, Texas
2014-01-16
Active, closed
A Study Evaluating the Safety, Pharmacokinetics (PK), and Preliminary Efficacy of ABBV-399 in Participants With Advanced Solid Tumors
NCT02099058Advanced Solid Tumors Cancer
AbbVie
Phase 1
237
Arizona, California, Colorado, Illinois, Massachusetts, Michigan, Missouri, New Jersey
2014-01-15
Active, closed
NOVOCART®3D for Treatment of Articular Cartilage of the Knee
NCT01957722Articular Cartilage of the Femoral Condyle Between 2-6cm2
Aesculap Biologics, LLC
Phase 3
233
California, Colorado, Florida, Idaho, Illinois, Kentucky, Louisiana, Michigan
2013-12
Active, closed
A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer
NCT01946204Prostatic Neoplasms
Aragon Pharmaceuticals, Inc.
Phase 3
1,207
Alabama, Alaska, Arizona, California, Colorado, District of Columbia, Florida, Idaho
2013-10-14
Active, closed
Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLC
NCT01933932Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
AstraZeneca
Phase 3
510
Colorado, Florida, Georgia, Illinois, Louisiana, Massachusetts, New York, North Carolina
2013-09-25
Active, closed
Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
NCT01874353Platinum Sensitive, BRCA Mutated, Relapsed Ovarian Cancer, Following Complete or Partial Response to Platinum Based Chemotherapy
AstraZeneca
Phase 3
327
Alabama, California, Colorado, Connecticut, Florida, Illinois, Maryland, Massachusetts
2013-09-03
Active, closed
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
NCT01844986Newly Diagnosed, Advanced Ovarian Cancer, FIGO Stage III-IV, BRCA Mutation
AstraZeneca
Phase 3
450
Alabama, Alaska, Arizona, California, Colorado, Connecticut, Florida, Georgia
2013-08-26
Active, closed
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
NCT01848561Ulcerative Colitis (UC)
AbbVie
Observational
8,250
Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida
2013-04-29
Recruiting
Atypical Hemolytic-Uremic Syndrome (aHUS) Registry
NCT01522183Atypical Hemolytic-Uremic Syndrome
Alexion Pharmaceuticals, Inc.
Observational
3,000
Colorado, District of Columbia, Florida, Georgia, Illinois, Massachusetts, Missouri, North Carolina
2013-03-18
Active, closed
Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia B
NCT01687608Hemophilia B
Baxalta now part of Shire
Phase 1/2
30
California, Colorado, Georgia, Illinois, Massachusetts, Minnesota, New York, Oregon
2013-02-11
Active, closed
Study to Evaluate the Antiviral Efficacy, Safety and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Pediatric Participants With Chronic Hepatitis B Infection
NCT01651403Chronic Hepatitis B
Gilead Sciences
Phase 3
90
Arizona, California, Colorado, Ohio, Texas
2012-12-06
Recruiting
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
NCT01719055Pain
Boston Scientific Corporation
Observational
4,800
Arizona, California, Colorado, Florida, Georgia, Illinois, Indiana, Kansas
2012-11-19
Active, closed
Safety and Efficacy Study of the Xoft® Axxent® eBx® IORT System®
NCT01644669Invasive Ductal Carcinoma, Ductal Carcinoma in Situ
Xoft, Inc.
Not applicable
1,200
Arizona, California, Colorado, Florida, Illinois, Indiana, Maryland, New Hampshire
2012-05-08
Recruiting
Patient Retrospective Outcomes (PRO)
NCT01550575Chronic Pain
Boston Scientific Corporation
Observational
15,000
Arizona, California, Colorado, Connecticut, Florida, Georgia, Hawaii, Idaho
2012-04-03
Recruiting
Product Surveillance Registry
NCT01524276Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders
Medtronic
Observational
100,000
Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida
2012-01
Active, closed
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
NCT01436968Prostate Cancer
Candel Therapeutics, Inc.
Phase 3
711
Arizona, California, Colorado, District of Columbia, Florida, Illinois, Louisiana, Maryland
2011-09
Active, closed
Zimmer Continuum Metal on Polyethylene (MoP) PostMarket Clinical Followup (PMCF) Study
NCT01307384Avascular Necrosis, Osteoarthritis, Inflammatory Arthritis, Post-traumatic Arthritis
Zimmer Biomet
Observational
165
California, Colorado
2011-03-29
By invitation
Post-Approval Study of the Implantable Miniature Telescope
NCT01757132AMD
VisionCare, Inc.
Not applicable
770
Arizona, California, Colorado, Florida, Georgia, Michigan, Missouri, New York
2010-08
Active, closed
Registry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction
NCT01526681Peripheral Nerve Injuries
Axogen Corporation
Observational
3,126
Arizona, California, Colorado, District of Columbia, Florida, Georgia, Kansas, Kentucky
2008-11
Active, closed
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
NCT00781612Neoplasm Metastasis
Genentech, Inc.
Phase 2
378
California, Colorado, Delaware, Florida, Georgia, Idaho, Illinois, Indiana
2008-10-16
Recruiting
Exactech Shoulder Post Market Clinical Follow-up Study
NCT05603728Osteo Arthritis Shoulders, Osteonecrosis, Rotator Cuff Tears, Rotator Cuff Tear Arthropathy
Exactech
Observational
20,000
California, Colorado, Florida, Georgia, Illinois, Michigan, New York, North Carolina
2007-07-19
Active, closed
Psoriasis Longitudinal Assessment and Registry
NCT00508547Psoriasis
Janssen Scientific Affairs, LLC
Observational
20,167
Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia
2007-06-21
Active, closed
A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease
NCT00606346Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis, Inflammatory Bowel Diseases
Janssen Biotech, Inc.
Observational
4,970
Alabama, Arizona, California, Colorado, Connecticut, Florida, Georgia, Idaho
2007-05-31
Active, closed
AZD6244 (ARRY-142886) Solid Oral Dosage Formulation in Participants With Advanced Solid Malignancies
NCT00463814Tumor, Cancer
AstraZeneca
Phase 1
58
Colorado
2007-03-08
Active, closed
PhII ICb With/Without Erbitux in MBC Pts
NCT00248287Metastatic Breast Cancer
US Oncology Research
Phase 2
154
Alabama, Arizona, Colorado, Connecticut, Florida, Illinois, Indiana, Kansas
2005-07-28
Recruiting
Pompe Disease Registry Protocol
NCT00231400Glycogen Storage Disease Type II, Pompe Disease
Genzyme, a Sanofi Company
Observational
2,000
Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida
2004-09-15
Recruiting
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
NCT00271180Arrhythmia, Bradycardia, Heart Failure, Sinus Tachycardia
Medtronic
Observational
20,000
Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia
1983-01
Rows per page Showing 2001–2067 of 2067
Previous 19 20 21
Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a US investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-usa/state/colorado?page=21

Query this register directly
GET /api/trials?country=usa&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every industry-sponsored study on the registry that lists at least one investigative site in the US and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,115 studies in total at the last sync on 24 Sep 2026, 03:16 UTC. Academic and other non-industry sponsors are out of scope by design. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 2,067 of those studies with a site in Colorado.

How many clinical trials are recruiting in Colorado?

1,027 of the 2,067 studies on this page are recruiting new participants as of the 24 Sep 2026, 03:16 UTC sync. A further 29 have not yet opened recruitment, 946 are active but closed to new participants, and 65 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish, UK and EU sites, see the Ireland, UK and EU registers.